{"name":"Madrigal Pharmaceuticals, Inc.","slug":"madrigal-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"MGL-3196","genericName":"MGL-3196","slug":"mgl-3196","indication":"Non-alcoholic fatty liver disease (NAFLD) with elevated transaminases","status":"phase_3"}]}],"pipeline":[{"name":"MGL-3196","genericName":"MGL-3196","slug":"mgl-3196","phase":"phase_3","mechanism":"MGL-3196 is a thyroid hormone receptor beta (THR-β) selective agonist that activates THR-β to reduce cholesterol and triglycerides while minimizing systemic thyroid hormone effects.","indications":["Non-alcoholic fatty liver disease (NAFLD) with elevated transaminases","Dyslipidemia and cholesterol management in patients with cardiovascular risk"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2wJBVV95cUxNUmV5VXNHVl9QYTlSUklkOGRQdHpPMGEwMmRnb2s0STJFdjh3S0JvTlZaU0NQZi1BWk9zMmM2aGt2TkpxMlZfd1FxTEpHUDdTWTlHbjZpazd6ZmZYek9rWERvenQzc1Y5UkVBeE5VXzVrd2NpVXlqaG44YmxfeFV4VnY2MFM3RDJyLUg0OUVoTE9iaE5iS05WQXVHU0F4cWN5cXZIRXo0TFpmem9nSGNwbFE4QjY4SDVILTh0azdDY1RrNi12ZmFBY2tNc29vTDNWYnhDZkpZUTh4dHp5d1lDVlhXY3hFYWxYdzhBQml6SU9NVTBOS0JYRG1uZThKaXM1TkhyeFYwU0QyMjhQOXNQcXp3RWdIZFJNSmdLb2twTVB5ZUp5X250cW50N3Z1ZUh1NUtENlV1VHFSVUt4SERCNkdQMFgwcmV2VExMOC05ZGdmdjJBM3ZkR2JpTQ?oc=5","date":"2026-04-08","type":"deal","source":"msn.com","summary":"What makes Madrigal Pharma (MDGL) one of the shorted biotech stocks to buy - msn.com","headline":"What makes Madrigal Pharma (MDGL) one of the shorted biotech stocks to buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQMzRBZ0hJX1JISVNQUG9jX1Q4UU5VeHpJSTItSkQ2TExMb1RSdkh6bmVydFBJdWRkWjd5bGROZ29YcTlRMC1weGlMTnUxTHFhN0pWYXFLeXZUNW4za3U0WUtZd3Qyai1BNlFoOUFoZmstdXVXcGU1Ni1RM2JyQzU3amdvbWVZS2lRVzl4dzRrQ0ZzVllfTUZnZUZPcmhvOHl3ZE82elpPN0dmR3JtV3R6R2Fqckh0QTJWQ1RyQVU0cGZzb01xaXc?oc=5","date":"2026-03-26","type":"deal","source":"Stocktwits","summary":"MDGL Stock Surges Most In A Month On Eli Lilly Buyout Speculation - Stocktwits","headline":"MDGL Stock Surges Most In A Month On Eli Lilly Buyout Speculation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNeHBTSHJyUzlXeDdDNmpzM2hsRUw5WmMtRXVRakQ5NTNIUFE5eV9xOWhJLTNOQ1E1ckwwSmlfVlYybUNoYXM4WlJzdWRaSUZyUVU0VEZXUVpLMmotQWlmUGlockpKYkZ1cEpBNGxWeXhNdWpmazBJeXVidHNVbGR6YklleFBnV3dxWGh3Tk9CNWc1eGZMNTRsc05yenVBS242NmhqaUZ4TzRXWTRlTWV1TmlDU3dpZzFvdEVUb3pNbGY?oc=5","date":"2026-03-05","type":"pipeline","source":"Stock Titan","summary":"20 new Madrigal staff get stock options and 6,882 RSUs at $432 - Stock Titan","headline":"20 new Madrigal staff get stock options and 6,882 RSUs at $432","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPR210c204NTNIN0gzZmw3WlF6dFdqdTVaUl8xWmgxeDNIcnNIbTF5Ri1YVjNWbzhHWC1DVFctLTNEaTJZWTJBVTRnQ0hpdGpaVHdDWXR5VFU2Tk5ESTBWbXYxS3R4Q3pqUEdTUkFmVHVfbXkyZjdnejdoeUw1aDNZTFduMU1BaUxIcnpidWc5dkMzeTdYYW9MVHB4a0QtNktCdXQ3NWpuTnJkdw?oc=5","date":"2026-02-19","type":"pipeline","source":"GuruFocus","summary":"Decoding Madrigal Pharmaceuticals Inc (MDGL): A Strategic SWOT I - GuruFocus","headline":"Decoding Madrigal Pharmaceuticals Inc (MDGL): A Strategic SWOT I","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNal9nWXd2eXFKOF9RdXRWcG5zMlpJbTlvVGxIalZxU2dGb25vZ1JVVzBDT2JSbHdoUGUxVFRjNnpVQzc1NHpNdUp0OElQMUNnTC02RU5jbzRkbmFER2JDRmlodFk3c1c3MzJFRy1RZzNUTjVtZGJ4R25Pdm9uS2JhZ1JwaENBRUpsVF8yUVdzYXc2a0RVcWxER0ZYZWlzd1Y1R3BEVUZHNlQ3OWV4bERQbWRkOHg2MTFjYjlDaURMTzNmbF80elJlcmNEQng?oc=5","date":"2026-02-19","type":"earnings","source":"Investing.com","summary":"Madrigal Pharma shares fall over 5% as Q4 earnings miss overshadows revenue beat - Investing.com","headline":"Madrigal Pharma shares fall over 5% as Q4 earnings miss overshadows revenue beat","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPeGlXN3dHamJEWlZ5dWY2Ny1rTXk0cGVFWjlnRUpZYXpzRGRNVkJ2TnNkbUxBeVdreUhXcHQ5d1hJLXVBYWpERXlZZnFJX09IVWY4aXlSUDVseHFSR1Q4VEpqX2FMTzdoYXU4ZEszdzZtWmd6cFc1YjlTWHRCOEt2bUFEME82OWgyelA5RTZOSVFIdzl3NGNYY1h0MHJ2VnNtWWdvVE9XTQ?oc=5","date":"2026-02-17","type":"earnings","source":"Seeking Alpha","summary":"Madrigal Pharmaceuticals: What To Expect With Q4 Earnings Coming Thursday - Seeking Alpha","headline":"Madrigal Pharmaceuticals: What To Expect With Q4 Earnings Coming Thursday","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxOY3dOVmhtUTlORWk0Z2tqOXpuRjdoNTM0STNaMFpNdElRXzY5UnJtQlhiME1VajVIRXJqS3BKWGQxcGp5bnRLQlZQR2lkTFBxeWRhZ3JsZVdaUE5BYjNmd1NGOXhvZzBFWTloQUhzVnIxcTNsUlNWSmYzSnIxTC1Ia2VpenhwRmRabEF3TVlZQzlHcXBNQVhNWjNuWjFta0JiRHpySElUN1JxLUl1d3ZYWGxXc2Y5a0FENGljd3RmNWhacDFzLXhUSUlNY3d4VEk?oc=5","date":"2026-01-14","type":"pipeline","source":"Pharmaceutical Technology","summary":"JPM26: Madrigal seeks early dominance in MASH through strategic acquisitions - Pharmaceutical Technology","headline":"JPM26: Madrigal seeks early dominance in MASH through strategic acquisitions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE5tWF9sWC03Z0NfYVNkUHF6WXZLck5YcjdCQTY1Tk40eFhOTTV4d1FHRDBKZ0ltbXBsRjZCbWUxLWtYaXJRY0dKd0VObGNLUjdvYmtuZzhPdVh5d2tWTHhjZlk0WXBZb1NGMjlNZG1VcXJ5VjBkb0ZZ?oc=5","date":"2026-01-09","type":"pipeline","source":"Seeking Alpha","summary":"Pfizer in pact with Madrigal for MASH drug (MDGL:NASDAQ) - Seeking Alpha","headline":"Pfizer in pact with Madrigal for MASH drug (MDGL:NASDAQ)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPcnBaYlF5dTFjbDQ1UGdSYk9SZFBxQ0ozQjVZdUY5N29Vc1diZVljaDNhb29kQWpTQ0pyc1BIUlUwUFljNnlBR3NSMGJrUFZuRUZNd0lsb2ZlOHJaVVVjWEhOMUtqRlJIY2o5N3RYV1VtRllfUEYyeVRFRHJnYlNQYUNwODVDN2lVYkZydEx0c0VKNzlqV0RRR1ZRZmI2Um5WdGYxQWZDYzlRS0FjRUY4cWNiaw?oc=5","date":"2025-12-03","type":"pipeline","source":"Investing.com","summary":"Madrigal Pharma EVP Dier sells $2.4m in MDGL stock - Investing.com","headline":"Madrigal Pharma EVP Dier sells $2.4m in MDGL stock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxPbmd1a3Nmbjh6TkUwNlNsWmswc25ZbGpsTXBsaFhtY2RJTnBRcGdWRDdGd2c2VWR6UjhiVkZmQ2JGRTJIajlIMHZQblVocVZzT19uV29uZEdaUlQ5ekdQT2pxS3ROV1oyU1o0NEthWnplRnVxTkZzOEZlRlFRXzFZNFpNcU5nTDJxUGt5LU5ra2c0eDY4RTlZYUwtMnVJNW1qQTRNUUV0Y0xqbkp0TXA1SUd4d1o3UE1qRUZoWDRiZmlmS29EclFNZHl4MmQ4dm5VY3lJUVp1OUJTa1ViY2wyZFBvZzJIcExtcU1EZjZVWHo?oc=5","date":"2025-11-24","type":"deal","source":"Stocktwits","summary":"Madrigal Pharma Stock Sees Buyout Hype – Retail Predicts ‘Huge’ Deal On Liver Disease Drug Momentum - Stocktwits","headline":"Madrigal Pharma Stock Sees Buyout Hype – Retail Predicts ‘Huge’ Deal On Liver Disease Drug Momentum","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxNR1VNcGYyaXB6dURuQ0hTUVFYTEFVQU13OFRXenZVUnZodk1EVW9oWlNHUWZoZHZlWlhRWFNBeGlUR0pDeWpsdlNJb19QYnJubWFRNC1qVFVZblRiYmZoV1c3UnpvOGp6RXpUd0VNUUpNM1NadTR5WWgzSlJlUWpVWUxVWjlSZFZtdVFIdWxjc3RTczFkU09zM3Q5TFgydTdWdHZtUFg3Q3dFZGlyODhLc2JidkFZc3lTVjVVZDdVSFllVzBVOWVPZURuR1Y0Z180RUtBLUltY0lUbWo2OW1mT0x2eDFiRktROVo4a2l5YWFIYUpJaWRyc0xVdWM0eDU2dkE?oc=5","date":"2025-11-04","type":"earnings","source":"GlobeNewswire","summary":"Madrigal Pharmaceuticals Reports Third-Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewswire","headline":"Madrigal Pharmaceuticals Reports Third-Quarter 2025 Financial Results and Provides Corporate Updates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugJBVV95cUxNSGs4TTlCR0JJS1haVVRDSVBwVmI5RGdJR3A0a1BSTFFyNk94eHZ0ekdZS0NWRHhUYWFGODkwbW4wUk41VVBrMkxQNU15T1d0UVpwSF9ncXZiZENnbUZycTVxVzBJWFdvNHdSNEZ2NThnT3pacVZ0NEpEZHcyZ2tjUjhmalI5SkFYb2Jaa1Rkc194UHBTeDdaY0g2WW5OTnlOVHFrci1nVWpVODNlV2RBdHpiNFlVMUJxOUg3YVRCS3ctaW1iQW1xRXpoTEloUDg2VlhfdURxSGZtRFdockM2NktLTC1mZkxOdnJQU253VzlkbUdPTVROQjlaZ0c2a1BHcUxhLURKNHREdWZCdXVVSWQ4NGppd0FuNW9yVVptU1dPODBpMXJsT1IyMUhZbTVyOVpmY2pycWQ4dw?oc=5","date":"2025-07-30","type":"pipeline","source":"GlobeNewswire","summary":"Madrigal Pharmaceuticals Enters into Exclusive Global - GlobeNewswire","headline":"Madrigal Pharmaceuticals Enters into Exclusive Global","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}